Back
Coupa Software 10K Form
Buy
71
COUP
Coupa Software
Last Price:
79.86
Seasonality Move:
2.77%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2020-09-08 | 10Q | COUP/Coupa Software Quarterly |
2020-06-08 | 10Q | COUP/Coupa Software Quarterly |
2020-03-20 | 10K | COUP/Coupa Software Annual |
2019-12-03 | 10Q | COUP/Coupa Software Quarterly |
2019-09-05 | 10Q | COUP/Coupa Software Quarterly |
2019-06-04 | 10Q | COUP/Coupa Software Quarterly |
Receive COUP News And Ratings
See the #1 stock for the next 7 days that we like better than COUP
COUP Financial Statistics
Sales & Book Value
Annual Sales: | $725.29M |
---|---|
Cash Flow: | $65.53M |
Price / Cash Flow: | 30.62 |
Annual Sales: | $3.73 |
Price / Book: | 21.43 |
Profitability
EPS (TTM): | -4.47000 |
---|---|
Net Income (TTM): | $-337.43M |
Gross Margin: | $412.05M |
Return on Equity: | -61.07% |
Return on Assets: | -10.64% |
Coupa Software Earnings Forecast
Key Coupa Software Financial Ratios
- The Gross Profit Margin over the past 8 years for COUP is 56.81%.
- The Selling, General & Administrative Expenses for COUP have been equal to 67.51% of Gross Profit Margin.
- The Research & Development expenses have been 22.95% of Revenue.
- The Interest Expense is -32.38% of Operating Income.
- The Net Earning history of COUP is -52.26% of Total Revenues.
- Per Share Earnings over the last 8 years have been positive in 1 years.
Coupa Software Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Software - Application |
Sector: | Technology |
Current Symbol: | COUP |
CUSIP: | 22266L |
Website: | coupa.com |
Debt
Debt-to-Equity Ratio: | 7.62 |
---|---|
Current Ratio: | 1.78 |
Quick Ratio: | 1.69 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 114.42 |
COUP Technical Analysis vs Fundamental Analysis
Buy
71
Coupa Software (COUP)
is a Buy
Is Coupa Software a Buy or a Sell?
-
Coupa Software stock is rated a Buy
The current Coupa Software [COUP] share price is $79.87. The Score for COUP is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.